Filing Details
- Accession Number:
- 0001415889-24-019343
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-08 16:30:13
- Reporting Period:
- 2024-02-19
- Accepted Time:
- 2024-07-08 16:30:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1937482 | Yong Yu | C/O Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | Vp, Clinical Trial Operations | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-19 | 3,661 | $0.00 | 6,161 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-03-14 | 11,557 | $0.00 | 17,718 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-06-24 | 6,849 | $2.12 | 10,869 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024.
- Represents RSUs that are fully vested as of March 14, 2024.
- Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of RSUs.
Billionaire Hedge Funds
